Akèy › Sipwa › North Carolina › Raleigh

Etid klinik pou Sipwa nan Raleigh, NC

5 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Raleigh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3

Accellacare of Raleigh, Raleigh

Laj 45 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07037433

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3

Accellacare of Raleigh, Raleigh

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3

AURORA-2 Clinical Site, Raleigh

Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3

AURORA-1 Clinical Site, Raleigh

Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3

Accellacare of Raleigh, Raleigh

Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

Etid Sipwa nan lòt vil

Lòt etid nan Raleigh

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.